165 related articles for article (PubMed ID: 31361893)
1. Prognostic value of the expression of epithelial cell adhesion molecules in head and neck squamous cell carcinoma treated by definitive radiotherapy.
Murakami N; Mori T; Nakamura S; Yoshimoto S; Honma Y; Ueno T; Kobayashi K; Kashihara T; Takahashi K; Inaba K; Okuma K; Igaki H; Nakayama Y; Itami J
J Radiat Res; 2019 Nov; 60(6):803-811. PubMed ID: 31361893
[TBL] [Abstract][Full Text] [Related]
2. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.
Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J
Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563
[TBL] [Abstract][Full Text] [Related]
3. Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas.
Schinke H; Heider T; Herkommer T; Simon F; Blancke Soares A; Kranz G; Samaga D; Dajka L; Feuchtinger A; Walch A; Valeanu L; Walz C; Kirchner T; Canis M; Baumeister P; Belka C; Maihöfer C; Marschner S; Pflugradt U; Ganswindt U; Hess J; Zitzelsberger H; Gires O
Mol Oncol; 2021 Apr; 15(4):1040-1053. PubMed ID: 33340247
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activation.
Noman ASM; Parag RR; Rashid MI; Islam S; Rahman MZ; Chowdhury AA; Sultana A; Jerin C; Siddiqua A; Rahman L; Nayeem J; Akther S; Baidya S; Shil RK; Rahman M; Shirin A; Mahmud R; Hossain SMI; Sumi SA; Chowdhury A; Basher SB; Hasan A; Bithy S; Aklima J; Chowdhury N; Hasan MN; Banu T; Chowdhury S; Hossain MM; Yeger H; Farhat WA; Islam SS
Cell Death Dis; 2020 Aug; 11(8):663. PubMed ID: 32814771
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
Haehl E; Rühle A; David H; Kalckreuth T; Sprave T; Stoian R; Becker C; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Feb; 15(1):31. PubMed ID: 32019576
[TBL] [Abstract][Full Text] [Related]
6. The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.
Zhou C; Shen Z; Ye D; Li Q; Deng H; Liu H; Li J
Cell Physiol Biochem; 2018; 50(3):868-882. PubMed ID: 30355925
[TBL] [Abstract][Full Text] [Related]
7. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Epithelial Cell Adhesion Molecule and Cytokeratin 8 in Head and Neck Squamous Cell Cancer: A Comparative Study.
Andratschke M; Hagedorn H; Nerlich A
Anticancer Res; 2015 Jul; 35(7):3953-60. PubMed ID: 26124342
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Epithelial Cell Adhesion Molecules in T1-2N0M0 Glottic Cancer.
Murakami N; Mori T; Machida R; Kodaira T; Ito Y; Shikama N; Konishi K; Matsumoto Y; Murakami Y; Nakamura N; Yamashita H; Yorozu A; Yoshimura M; Inoue K; Nozaki M; Ishikura S; Itami J; Nishimura Y; Kagami Y
Laryngoscope; 2021 Jul; 131(7):1522-1527. PubMed ID: 33369763
[TBL] [Abstract][Full Text] [Related]
10. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
[TBL] [Abstract][Full Text] [Related]
11. Survivin expression and impact on head and neck cancer outcomes.
Khan SA; Burke M; Zhu F; Yang DH; Dubyk C; Mehra R; Lango MJ; Ridge JA; Sher DJ; Burtness B
Oral Oncol; 2021 Jan; 112():105049. PubMed ID: 33221541
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532
[TBL] [Abstract][Full Text] [Related]
13. The roles of PTEN, cMET, and p16 in resistance to cetuximab in head and neck squamous cell carcinoma.
da Costa AABA; Costa FD; Araújo DV; Camandaroba MPG; de Jesus VHF; Oliveira A; Alves ACF; Stecca C; Machado L; de Oliveira ACF; de Oliveira TB; Nicolau UR; de Lima VCC
Med Oncol; 2018 Nov; 36(1):8. PubMed ID: 30478503
[TBL] [Abstract][Full Text] [Related]
14. Extranodal Extension and Epithelial Cell Adhesion Molecule Over-expression in Oral Squamous Cell Carcinoma.
Fukushima H; Naruse T; Furukawa K; Omori K; Miyoshi T; Miura KI; Otsuru M; Umeda M
Anticancer Res; 2023 Nov; 43(11):5155-5166. PubMed ID: 37909986
[TBL] [Abstract][Full Text] [Related]
15. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
[TBL] [Abstract][Full Text] [Related]
16. Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.
Seligson DB; Pantuck AJ; Liu X; Huang Y; Horvath S; Bui MH; Han KR; Correa AJ; Eeva M; Tze S; Belldegrun AS; Figlin RA
Clin Cancer Res; 2004 Apr; 10(8):2659-69. PubMed ID: 15102668
[TBL] [Abstract][Full Text] [Related]
17. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
18. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
Guo YZ; Sun HH; Wang XT; Wang MT
J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-modulated Radiotherapy.
Ahmad P; Sana J; Slavik M; Gurin D; Radova L; Gablo NA; Kazda T; Smilek P; Horakova Z; Gal B; Hermanova M; Slampa P; Slaby O
Cancer Genomics Proteomics; 2019; 16(2):139-146. PubMed ID: 30850365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
